Uppsala, Sweden

Per Erik Andren

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 1 EPO patent. Top assignee: Axon Biochemicals B.v.. Active years: 2007-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Per Erik Andren. Retrieved from https://idiyas.com/inventor/per-erik-andren

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0



Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2007-2008

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Per Erik Andren: Innovator in Aporphine Derivatives

Introduction

Per Erik Andren is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new therapeutic agents. With a total of 2 patents to his name, Andren's work focuses on innovative solutions for various medical conditions.

Latest Patents

Andren's latest patents include groundbreaking research on aporphine esters and their therapeutic applications. These new aporphine derivatives, which are described by a specific formula, have shown potential in treating Parkinson's disease, hemicrania, restless legs syndrome (RLS), sexual dysfunction in both men and women, hyperprolactinemia, and psychotic disorders. Additionally, the patents detail processes for the preparation of these derivatives, highlighting their importance in the evaluation and treatment of Parkinson's disease.

Career Highlights

Throughout his career, Andren has worked with several prominent companies, including Axon Biochemicals B.V. and Denator AB. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to significant advancements in medical research.

Collaborations

Andren has collaborated with notable professionals such as Hakan Wikstrom and Durk Dijkstra. These partnerships have further enriched his research and development efforts, leading to innovative solutions in the pharmaceutical industry.

Conclusion

Per Erik Andren's contributions to the field of pharmaceuticals, particularly through his patents on aporphine derivatives, demonstrate his commitment to advancing medical science. His work continues to have a positive impact on the treatment of various health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…